• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » Good Start Genetics repays $500,000 state loan

Good Start Genetics repays $500,000 state loan

September 20, 2010 By MassDevice staff

GSG logo

Good Start Genetics Inc., which earlier this month raised $18 million in venture financing, has repaid its debt to the Commonwealth in full, or at least until next tax season.

The Boston-based company, which is developing a pre-pregnancy genetic test designed to screen for a panel of genetic disorders, won a $500,000 “accelerator” loan from the Massachusetts Life Sciences Center in April 2009. It’s the first of the seven companies to receive the state’s assistance to pay off its loan.

Good Start announced Sept. 10 that it had raised $18 million in a Series A round led by OrbiMed Advisors, Safeguard Scientifics Inc. (NYSE:SFE) and SV Life Sciences.

At an intimate ceremony in Boston University’s Photonics Center, where the company has offices and lab space in the school’s business incubator, Mass. Life Science Center president Susan Windham-Bannister said the repayment was a major step forward for the quasi-public agency’s mission of helping to foster innovation in the life science industry.

Good Start Genetics pays off Mass. Life Sciences Center loan

Peter Abair of MassBio; Good Start Genetics co-founder Paris Wallace; Good Start Genetics president & CEO Don Hardison; MLSC president & CEO Susan Windham-Bannister; Boston University’s Stephen Ober
Photo courtesy MLSC

“When we developed this program, it was our belief that if the state stepped forward and made some investments in early-stage companies when they were still risky, then the investment community would come in behind us,” Windham-Bannister told MassDevice. “This repayment is proof-of-concept for what we’re trying to do.”

Good Start’s new CEO, Don Hardison, said the state’s involvement in the fledgling company made it an attractive option when he was considering joining the firm.

“The fact that there was some funding there to get started was critical,” Hardison told us, adding that the state’s imprimatur in giving the loan was something that impressed him.

Good Start has already hired three more employees since landing the A round at the start of the month, he added, bringing its total workforce to 12, with an expected eight more to come before year’s end, he said.

Good Start officially paid the state more than $62,000 in interest on the loan.

Filed Under: Business/Financial News, Diagnostics, Genomics/Molecular Diagnostics, News Well Tagged With: Good Start Genetics Inc.

More recent news

  • Breaking: Sequel to launch twiist automated insulin delivery system next month
  • Dexcom shares U.S. report on CGM benefits for type 2 diabetes
  • Data backs Medtronic MiniMed 780G for type 2, children as company seeks expanded indications
  • Endogenex data supports type 2 diabetes procedure
  • Ambu wins FDA clearance for first single-use cysto-nephroscope

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy